Technical Analysis for PETQ - PetIQ, Inc.

Grade Last Price % Change Price Change
C 20.00 0.15% 0.03
PETQ closed up 0.81 percent on Friday, May 17, 2024, on 88 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.15%
NR7 Range Contraction 0.15%
Narrow Range Bar Range Contraction 0.15%
Multiple of Ten Bearish Other 0.15%
Overbought Stochastic Strength 0.15%
Up 3 Days in a Row Strength 0.15%
Up 4 Days in a Row Strength 0.15%
Up 5 Days in a Row Strength 0.15%
180 Bullish Setup Bullish Swing Setup 0.96%
Slingshot Bullish Bullish Swing Setup 0.96%

   Recent Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PetIQ, Inc. Description

PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Retail Store Drugs Pain Diabetes Antibiotics Dog Control Products Arthritis Wellness Products Insecticide Rheumatology E Commerce Channels Wellness Rimadyl

Is PETQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.98
52 Week Low 12.19
Average Volume 293,483
200-Day Moving Average 18.44
50-Day Moving Average 17.37
20-Day Moving Average 17.72
10-Day Moving Average 18.84
Average True Range 0.63
RSI (14) 75.85
ADX 33.29
+DI 46.84
-DI 13.17
Chandelier Exit (Long, 3 ATRs) 18.15
Chandelier Exit (Short, 3 ATRs) 17.77
Upper Bollinger Bands 20.33
Lower Bollinger Band 15.11
Percent B (%b) 0.93
BandWidth 29.43
MACD Line 0.73
MACD Signal Line 0.41
MACD Histogram 0.3206
Fundamentals Value
Market Cap 582.88 Million
Num Shares 29.2 Million
EPS 0.44
Price-to-Earnings (P/E) Ratio 45.39
Price-to-Sales 0.51
Price-to-Book 2.20
PEG Ratio 2.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.44
Resistance 3 (R3) 20.40 20.20 20.36
Resistance 2 (R2) 20.20 20.08 20.22 20.33
Resistance 1 (R1) 20.09 20.01 20.15 20.13 20.31
Pivot Point 19.89 19.89 19.92 19.91 19.89
Support 1 (S1) 19.78 19.77 19.84 19.82 19.63
Support 2 (S2) 19.58 19.70 19.60 19.61
Support 3 (S3) 19.47 19.58 19.58
Support 4 (S4) 19.51